GT Biopharma GTBP
NASDAQ GTBP
$0.29 +0.01 (+3.58%)
As of: Aug 21, 2026 · 1:34 PM EDT

GT Biopharma (GTBP) Dividends payables (2025)

GT Biopharma (GTBP) posted quarterly Dividends payables of $144000.0 for Q3 2025, up 69.41% quarter-over-quarter from $85000.0 in Q2 2025.

GT Biopharma (GTBP) Dividends payables (2025) Analysis & Trends

GT Biopharma (GTBP) has reported Dividends payables for 1 consecutive years, with $144000.0 the latest figure, recorded in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Vertex Pharmaceuticals 139.20 Bn 131.35 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.09 Bn 78.10 Bn 3.93 Bn -
3 Argenx Se 65.25 Bn 60.07 Bn 1.37 Bn -
4 Moderna 59.04 Bn 53.90 Bn 52.00 Mn -
5 BeOne Medicines 42.04 Bn 36.94 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn -
7 BioNTech SE 28.04 Bn 9.65 Bn 668.28 Mn -
8 Insmed 27.50 Bn 26.33 Bn 358.27 Mn -
9 Royalty Pharma 27.34 Bn 26.50 Bn - -
10 GT Biopharma 8.85 Mn 8.85 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 144,000.00
Jun 30, 2025 85,000.00